Format

Send to

Choose Destination
Anticancer Res. 2004 Sep-Oct;24(5C):3321-6.

Immuno-cell therapy of cancer in Japan.

Author information

1
Japan Research Association of Immunotherapeutics and 2Seta Clinic, 4-20-18 Seta, Setagayaku, Tokyo 158-0095, Japan. egawa@j-immunother.com

Abstract

The immuno-cell therapy of cancer in Japan is in the phase of transition from therapeutic research to a more generalized option for all patients. A short history of cancer immunotherapy in Japan and its present status are summarized. In 1999, the first private clinic with a cell processing facility and specializing in immuno-cell therapy was established. Since then, the number of such clinics has increased. As a result, the number of patients who undergone the therapy has markedly increased. A summary of the clinical results of the therapy in 1401 patients treated in two leading clinics is also presented.

PMID:
15515427
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center